SCHEMBL10072013

SCHEMBL10072013

CCCOC(=O)c1cc2c(o1)c(NC(=O)c1ccccc1N=O)nn2C(=O)OCC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.36
ALDH1A1 P00352 8/20 0.35
ELANE P08246 4/20 0.34
RAB9A P51151 3/20 0.33
LMNA P02545 2/20 0.33
HTT P42858 1/20 0.33
GLA P06280 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KDM4E B2RXH2 4/20 0.33
HPGD P15428 3/20 0.33
ACR P10323 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
GAA P10253 1/20 0.32
KMT2A Q03164 1/20 0.32
DDX3X O00571 2/20 0.32
TP53 P04637 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4083791 0.88 LMNA (0.44) MAOBALDH1A1RAB9ALMNAGLA
SCHEMBL4084092 0.87 ALDH1A1 (0.49) ALDH1A1RAB9ANPSR1KDM4EHPGD
SCHEMBL4078418 0.86 HTT (0.43) MAOBALDH1A1ELANERAB9ALMNA
SCHEMBL653045 0.85 ALDH1A1 (0.52) ALDH1A1RAB9ALMNAGLANPSR1
SCHEMBL4084026 0.84 MAPT (0.42) ALDH1A1RAB9ALMNAHTTKDM4E
SCHEMBL4084062 0.83 ALDH1A1 (0.51) ALDH1A1RAB9AHTTNPSR1KDM4E
SCHEMBL4078532 0.83 RAB9A (0.39) MAOBALDH1A1RAB9ALMNAHTT
SCHEMBL4087183 0.82 RAB9A (0.45) ALDH1A1RAB9ALMNAHTTNPSR1
SCHEMBL4078553 0.81 KDM4E (0.44) ALDH1A1RAB9ALMNAHTTGLA
SCHEMBL4088619 0.81 GPR35 (0.42) ALDH1A1ELANERAB9AHTTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119641-B2 1H-furo[3,2-C]pyrazole compounds useful as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-02-21 US disclosed
US-20090239924-A1 1H-FURO[3,2-C]PYRAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239924-A1 1H-FURO[3,2-C]PYRAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS IGF1R, CDK1, CDK15 MAOB 2275/4885ALDH1A1 2682/4885ELANE 4823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.